{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:07:19Z","timestamp":1792678039726,"version":"4.5.0"},"reference-count":86,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Invariant NKT (iNKT) cells are a unique subset of T lymphocytes that rapidly carry out effector functions following activation with glycolipid Ags, such as the model Ag \u03b1-galactosylceramide. Numerous studies have investigated the mechanisms leading to Th1 and Th2 cytokine production by iNKT cells, as well as the effects of the copious amounts of cytokines these cells produce. Less is known, however, about the mechanisms of iNKT cell cytotoxicity. In this study, we investigated the effect of Ag availability and strength, as well as the molecules involved in iNKT cytotoxicity. We demonstrate that the iNKT cell cytotoxicity in vivo correlates directly with the amount of CD1d expressed by the targets as well as the TCR affinity for the target glycolipid Ag. iNKT cells from spleen, liver, and thymus were comparable in their cytotoxicity in vitro. Surprisingly, we show that the Ag-specific cytotoxicity of iNKT cells in vivo depended almost exclusively on the interaction of CD95 (Fas) with CD178 (FasL), and that this mechanism can be efficiently used for tumor protection. Therefore, unlike NK cells, which rely mostly on perforin\/granzyme-mediated mechanisms, the Ag-specific cytotoxicity of iNKT cells in vivo is largely restricted to the CD95\/CD178 pathway.<\/jats:p>","DOI":"10.4049\/jimmunol.1001018","type":"journal-article","created":{"date-parts":[[2010,7,26]],"date-time":"2010-07-26T20:59:40Z","timestamp":1280177980000},"page":"2721-2729","source":"Crossref","is-referenced-by-count":129,"title":["Antigen-Specific Cytotoxicity by Invariant NKT Cells In Vivo Is CD95\/CD178-Dependent and Is Correlated with Antigenic Potency"],"prefix":"10.1093","volume":"185","author":[{"given":"Gerhard","family":"Wingender","sequence":"first","affiliation":[{"name":"Division of Developmental Immunology, La Jolla Institute for Allergy and Immunology , La Jolla, CA 92037"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Krebs","sequence":"additional","affiliation":[{"name":"Department of Genetics, The Scripps Research Institute , La Jolla, CA 92037"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Beutler","sequence":"additional","affiliation":[{"name":"Department of Genetics, The Scripps Research Institute , La Jolla, CA 92037"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell","family":"Kronenberg","sequence":"additional","affiliation":[{"name":"Division of Developmental Immunology, La Jolla Institute for Allergy and Immunology , La Jolla, CA 92037"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2010,9,1]]},"reference":[{"key":"2025032411502935300_r1","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1021\/jm00012a018","article-title":"Structure-activity relationship of \u03b1-galactosylceramides against B16-bearing mice","volume":"38","author":"Morita","year":"1995","journal-title":"J. Med. Chem."},{"key":"2025032411502935300_r2","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1126\/science.278.5343.1626","article-title":"CD1d-restricted and TCR-mediated activation of v\u03b114 NKT cells by glycosylceramides","volume":"278","author":"Kawano","year":"1997","journal-title":"Science"},{"key":"2025032411502935300_r3","first-page":"293","article-title":"CD1-restricted T cells and tumor immunity","volume":"314","author":"Swann","year":"2007","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"2025032411502935300_r4","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1146\/annurev.immunol.23.021704.115742","article-title":"Toward an understanding of NKT cell biology: progress and paradoxes","volume":"23","author":"Kronenberg","year":"2005","journal-title":"Annu. Rev. Immunol."},{"key":"2025032411502935300_r5","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.it.2007.05.008","article-title":"NKT cells in immunoregulation of tumor immunity: a new immunoregulatory axis","volume":"28","author":"Terabe","year":"2007","journal-title":"Trends Immunol."},{"key":"2025032411502935300_r6","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nrmicro1657","article-title":"The unique role of natural killer T cells in the response to microorganisms","volume":"5","author":"Tupin","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"key":"2025032411502935300_r7","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.4049\/jimmunol.154.9.4333","article-title":"Cytotoxic NK1.1 Ag+ \u03b1\u03b2 T cells with intermediate TCR induced in the liver of mice by IL-12","volume":"154","author":"Hashimoto","year":"1995","journal-title":"J. Immunol."},{"key":"2025032411502935300_r8","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1046\/j.1365-2567.1996.d01-638.x","article-title":"Interleukin-12 induces cytotoxic NK1+ \u03b1\u03b2 T cells in the lungs of euthymic and athymic mice","volume":"88","author":"Anzai","year":"1996","journal-title":"Immunology"},{"key":"2025032411502935300_r9","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.4049\/jimmunol.156.7.2436","article-title":"LPS induces NK1.1+ \u03b1\u03b2 T cells with potent cytotoxicity in the liver of mice via production of IL-12 from Kupffer cells","volume":"156","author":"Takahashi","year":"1996","journal-title":"J. Immunol."},{"key":"2025032411502935300_r10","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1093\/intimm\/12.6.909","article-title":"Relative contribution of NK and NKT cells to the anti-metastatic activities of IL-12","volume":"12","author":"Takeda","year":"2000","journal-title":"Int. Immunol."},{"key":"2025032411502935300_r11","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.4049\/jimmunol.156.9.3366","article-title":"Liver NK1.1+CD4+ \u03b1\u03b2 T cells activated by IL-12 as a major effector in inhibition of experimental tumor metastasis","volume":"156","author":"Takeda","year":"1996","journal-title":"J. Immunol."},{"key":"2025032411502935300_r12","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1126\/science.278.5343.1623","article-title":"Requirement for V\u03b114 NKT cells in IL-12-mediated rejection of tumors","volume":"278","author":"Cui","year":"1997","journal-title":"Science"},{"key":"2025032411502935300_r13","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4049\/jimmunol.160.1.16","article-title":"Critical role of NK1+ T cells in IL-12-induced immune responses in vivo","volume":"160","author":"Kawamura","year":"1998","journal-title":"J. Immunol."},{"key":"2025032411502935300_r14","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.4049\/jimmunol.165.5.2665","article-title":"The anti-tumor activity of IL-12: mechanisms of innate immunity that are model and dose dependent","volume":"165","author":"Smyth","year":"2000","journal-title":"J. Immunol."},{"key":"2025032411502935300_r15","first-page":"561","article-title":"Antitumor activity of \u03b1-galactosylceramide, KRN7000, in mice with EL-4 hepatic metastasis and its cytokine production","volume":"10","author":"Nakagawa","year":"1998","journal-title":"Oncol. Res."},{"key":"2025032411502935300_r16","first-page":"1202","article-title":"Treatment of hepatic metastasis of the colon26 adenocarcinoma with an \u03b1-galactosylceramide, KRN7000","volume":"58","author":"Nakagawa","year":"1998","journal-title":"Cancer Res."},{"key":"2025032411502935300_r17","doi-asserted-by":"crossref","first-page":"6578","DOI":"10.4049\/jimmunol.166.11.6578","article-title":"Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by \u03b1-galactosylceramide in mice","volume":"166","author":"Nakagawa","year":"2001","journal-title":"J. Immunol."},{"key":"2025032411502935300_r18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3727\/096504001108747521","article-title":"Antitumor activity of \u03b1-galactosylceramide, KRN7000, in mice with the melanoma B16 hepatic metastasis and immunohistological study of tumor infiltrating cells","volume":"12","author":"Nakagawa","year":"2000","journal-title":"Oncol. Res."},{"key":"2025032411502935300_r19","doi-asserted-by":"crossref","first-page":"5690","DOI":"10.1073\/pnas.95.10.5690","article-title":"Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated V\u03b114 NKT cells","volume":"95","author":"Kawano","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025032411502935300_r20","first-page":"5102","article-title":"Antitumor cytotoxicity mediated by ligand-activated human V\u03b124 NKT cells","volume":"59","author":"Kawano","year":"1999","journal-title":"Cancer Res."},{"key":"2025032411502935300_r21","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1084\/jem.189.7.1121","article-title":"The natural killer T (NKT) cell ligand \u03b1-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells","volume":"189","author":"Kitamura","year":"1999","journal-title":"J. Exp. Med."},{"key":"2025032411502935300_r22","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.4049\/jimmunol.163.5.2387","article-title":"Cutting edge: inhibition of experimental tumor metastasis by dendritic cells pulsed with \u03b1-galactosylceramide","volume":"163","author":"Toura","year":"1999","journal-title":"J. Immunol."},{"key":"2025032411502935300_r23","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.4049\/jimmunol.165.3.1659","article-title":"\u03b1-Glycosylceramides enhance the antitumor cytotoxicity of hepatic lymphocytes obtained from cancer patients by activating CD3\u2212CD56+ NK cells in vitro","volume":"165","author":"Ishihara","year":"2000","journal-title":"J. Immunol."},{"key":"2025032411502935300_r24","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.4049\/jimmunol.167.6.3114","article-title":"Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells","volume":"167","author":"Metelitsa","year":"2001","journal-title":"J. Immunol."},{"key":"2025032411502935300_r25","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/intimm\/13.4.459","article-title":"NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma","volume":"13","author":"Smyth","year":"2001","journal-title":"Int. Immunol."},{"key":"2025032411502935300_r26","first-page":"1728","article-title":"IFN-\u03b3-mediated inhibition of tumor angiogenesis by natural killer T-cell ligand, \u03b1-galactosylceramide","volume":"100","author":"Hayakawa","year":"2002","journal-title":"Blood"},{"key":"2025032411502935300_r27","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1002\/1521-4141(200106)31:6<1720::AID-IMMU1720>3.0.CO;2-U","article-title":"Critical contribution of IFN-\u03b3 and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of \u03b1-galactosylceramide","volume":"31","author":"Hayakawa","year":"2001","journal-title":"Eur. J. Immunol."},{"key":"2025032411502935300_r28","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/eji.200535461","article-title":"Immediate antigen-specific effector functions by TCR-transgenic CD8+ NKT cells","volume":"36","author":"Wingender","year":"2006","journal-title":"Eur. J. Immunol."},{"key":"2025032411502935300_r29","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jim.2003.10.017","article-title":"The VITAL assay: a versatile fluorometric technique for assessing CTL- and NKT-mediated cytotoxicity against multiple targets in vitro and in vivo","volume":"285","author":"Hermans","year":"2004","journal-title":"J. Immunol. Methods"},{"key":"2025032411502935300_r30","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0198-8859(01)00382-2","article-title":"Human umbilical cord blood NK T cells kill tumors by multiple cytotoxic mechanisms","volume":"63","author":"Gansuvd","year":"2002","journal-title":"Hum. Immunol."},{"key":"2025032411502935300_r31","doi-asserted-by":"crossref","first-page":"834","DOI":"10.4049\/jimmunol.168.2.834","article-title":"Progression of armed CTL from draining lymph node to spleen shortly after localized infection with herpes simplex virus 1","volume":"168","author":"Coles","year":"2002","journal-title":"J. Immunol."},{"key":"2025032411502935300_r32","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1084\/jem.188.8.1521","article-title":"CD1d-mediated recognition of an \u03b1-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution","volume":"188","author":"Brossay","year":"1998","journal-title":"J. Exp. Med."},{"key":"2025032411502935300_r33","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0022-1759(02)00204-1","article-title":"CD1 tetramers: a powerful tool for the analysis of glycolipid-reactive T cells","volume":"268","author":"Sidobre","year":"2002","journal-title":"J. Immunol. Methods"},{"key":"2025032411502935300_r34","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1084\/jem.192.5.741","article-title":"Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers","volume":"192","author":"Matsuda","year":"2000","journal-title":"J. Exp. Med."},{"key":"2025032411502935300_r35","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0091-679X(04)75010-4","article-title":"Guidelines for the presentation of flow cytometric data","volume":"75","author":"Roederer","year":"2004","journal-title":"Methods Cell Biol."},{"key":"2025032411502935300_r36","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.4049\/jimmunol.161.4.1710","article-title":"CD1 expression defines subsets of follicular and marginal zone B cells in the spleen: \u03b22-microglobulin-dependent and independent forms","volume":"161","author":"Amano","year":"1998","journal-title":"J. Immunol."},{"key":"2025032411502935300_r37","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.4049\/jimmunol.160.7.3121","article-title":"CD1.1 expression by mouse antigen-presenting cells and marginal zone B cells","volume":"160","author":"Roark","year":"1998","journal-title":"J. Immunol."},{"key":"2025032411502935300_r38","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1146\/annurev.immunol.15.1.535","article-title":"Mouse CD1-specific NK1 T cells: development, specificity, and function","volume":"15","author":"Bendelac","year":"1997","journal-title":"Annu. Rev. Immunol."},{"key":"2025032411502935300_r39","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nri854","article-title":"The unconventional lifestyle of NKT cells","volume":"2","author":"Kronenberg","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"2025032411502935300_r40","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1084\/jem.20050953","article-title":"Differential antitumor immunity mediated by NKT cell subsets in vivo","volume":"202","author":"Crowe","year":"2005","journal-title":"J. Exp. Med."},{"key":"2025032411502935300_r41","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S1471-4906(01)01957-3","article-title":"Neighborhood politics: the immunoregulatory function of organ-resident liver endothelial cells","volume":"22","author":"Knolle","year":"2001","journal-title":"Trends Immunol."},{"key":"2025032411502935300_r42","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nri981","article-title":"Hepatic T cells and liver tolerance","volume":"3","author":"Crispe","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"2025032411502935300_r43","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4049\/jimmunol.0902880","article-title":"Mechanisms for glycolipid antigen-driven cytokine polarization by V\u03b114i NKT cells","volume":"184","author":"Sullivan","year":"2010","journal-title":"J. Immunol."},{"key":"2025032411502935300_r44","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/35097097","article-title":"A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells","volume":"413","author":"Miyamoto","year":"2001","journal-title":"Nature"},{"key":"2025032411502935300_r45","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1172\/JCI200420862","article-title":"The clinical implication and molecular mechanism of preferential IL-4 production by modified glycolipid-stimulated NKT cells","volume":"113","author":"Oki","year":"2004","journal-title":"J. Clin. Invest."},{"key":"2025032411502935300_r46","doi-asserted-by":"crossref","first-page":"4539","DOI":"10.4049\/jimmunol.171.9.4539","article-title":"Another view of T cell antigen recognition: cooperative engagement of glycolipid antigens by Va14Ja18 natural T(iNKT) cell receptor. [corrected]","volume":"171","author":"Stanic","year":"2003","journal-title":"J. Immunol."},{"key":"2025032411502935300_r47","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.1073\/pnas.0600285103","article-title":"Design of natural killer T cell activators: structure and function of a microbial glycosphingolipid bound to mouse CD1d","volume":"103","author":"Wu","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025032411502935300_r48","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/nature03407","article-title":"Recognition of bacterial glycosphingolipids by natural killer T cells","volume":"434","author":"Kinjo","year":"2005","journal-title":"Nature"},{"key":"2025032411502935300_r49","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0952-7915(02)00316-3","article-title":"NKT cells: conductors of tumor immunity?","volume":"14","author":"Smyth","year":"2002","journal-title":"Curr. Opin. Immunol."},{"key":"2025032411502935300_r50","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/ijc.10141","article-title":"Regulation of CD1d expression by murine tumor cells: escape from immunosurveillance or alternate target molecules?","volume":"98","author":"Fiedler","year":"2002","journal-title":"Int. J. Cancer"},{"key":"2025032411502935300_r51","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.4049\/jimmunol.178.5.2853","article-title":"Tumor cells loaded with \u03b1-galactosylceramide induce innate NKT and NK cell-dependent resistance to tumor implantation in mice","volume":"178","author":"Shimizu","year":"2007","journal-title":"J. Immunol."},{"key":"2025032411502935300_r52","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1084\/jem.20070458","article-title":"Cross-presentation of glycolipid from tumor cells loaded with \u03b1-galactosylceramide leads to potent and long-lived T cell mediated immunity via dendritic cells","volume":"204","author":"Shimizu","year":"2007","journal-title":"J. Exp. Med."},{"key":"2025032411502935300_r53","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1002\/anie.200454215","article-title":"The C-glycoside analogue of the immunostimulant \u03b1-galactosylceramide (KRN7000): synthesis and striking enhancement of activity","volume":"43","author":"Yang","year":"2004","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"2025032411502935300_r54","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1084\/jem.20031192","article-title":"Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand \u03b1-galactosylceramide","volume":"198","author":"Schmieg","year":"2003","journal-title":"J. Exp. Med."},{"key":"2025032411502935300_r55","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nature03408","article-title":"Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections","volume":"434","author":"Mattner","year":"2005","journal-title":"Nature"},{"key":"2025032411502935300_r56","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1084\/jem.20011836","article-title":"Surface cathepsin B protects cytotoxic lymphocytes from self-destruction after degranulation","volume":"196","author":"Balaji","year":"2002","journal-title":"J. Exp. Med."},{"key":"2025032411502935300_r57","doi-asserted-by":"crossref","first-page":"27802","DOI":"10.1074\/jbc.271.44.27802","article-title":"A cytosolic granzyme B inhibitor related to the viral apoptotic regulator cytokine response modifier A is present in cytotoxic lymphocytes","volume":"271","author":"Sun","year":"1996","journal-title":"J. Biol. Chem."},{"key":"2025032411502935300_r58","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.cellimm.2007.03.004","article-title":"Expression of high levels of human proteinase inhibitor 9 blocks both perforin\/granzyme and Fas\/Fas ligand-mediated cytotoxicity","volume":"245","author":"Cunningham","year":"2007","journal-title":"Cell. Immunol."},{"key":"2025032411502935300_r59","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nri819","article-title":"Cytotoxic T lymphocytes: all roads lead to death","volume":"2","author":"Barry","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"2025032411502935300_r60","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev.immunol.20.100201.131730","article-title":"Lymphocyte-mediated cytotoxicity","volume":"20","author":"Russell","year":"2002","journal-title":"Annu. Rev. Immunol."},{"key":"2025032411502935300_r61","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1084\/jem.191.1.105","article-title":"Augmentation of V\u03b114 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis","volume":"191","author":"Kaneko","year":"2000","journal-title":"J. Exp. Med."},{"key":"2025032411502935300_r62","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1002\/ijc.22019","article-title":"Chemotherapy pretreatment sensitizes solid tumor-derived cell lines to V\u03b124+ NKT cell-mediated cytotoxicity","volume":"119","author":"Mattarollo","year":"2006","journal-title":"Int. J. Cancer"},{"key":"2025032411502935300_r63","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1182\/blood.V97.7.2067","article-title":"TRAIL expression by activated human CD4+ V\u03b124 NKT cells induces in vitro and in vivo apoptosis of human acute myeloid leukemia cells","volume":"97","author":"Nieda","year":"2001","journal-title":"Blood"},{"key":"2025032411502935300_r64","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1046\/j.1365-2567.2000.00952.x","article-title":"Human invariant v\u03b124+ natural killer T cells activated by \u03b1-galactosylceramide (KRN7000) have cytotoxic anti-tumour activity through mechanisms distinct from T cells and natural killer cells","volume":"99","author":"Nicol","year":"2000","journal-title":"Immunology"},{"key":"2025032411502935300_r65","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/sj.leu.2402943","article-title":"Expression of CD1d by myelomonocytic leukemias provides a target for cytotoxic NKT cells","volume":"17","author":"Metelitsa","year":"2003","journal-title":"Leukemia"},{"key":"2025032411502935300_r66","doi-asserted-by":"crossref","first-page":"4458","DOI":"10.4049\/jimmunol.164.9.4458","article-title":"Analysis of human V\u03b124+CD4+ NKT cells activated by \u03b1-glycosylceramide-pulsed monocyte-derived dendritic cells","volume":"164","author":"Takahashi","year":"2000","journal-title":"J. Immunol."},{"key":"2025032411502935300_r67","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1182\/blood.V99.4.1259","article-title":"Sequential production of interferon-gamma by NK1.1+ T cells and natural killer cells is essential for the antimetastatic effect of \u03b1-galactosylceramide","volume":"99","author":"Smyth","year":"2002","journal-title":"Blood"},{"key":"2025032411502935300_r68","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1084\/jem.20020092","article-title":"A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas","volume":"196","author":"Crowe","year":"2002","journal-title":"J. Exp. Med."},{"key":"2025032411502935300_r69","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.4049\/jimmunol.163.9.4647","article-title":"Cutting edge: cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells","volume":"163","author":"Carnaud","year":"1999","journal-title":"J. Immunol."},{"key":"2025032411502935300_r70","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/(SICI)1521-4141(200004)30:4<985::AID-IMMU985>3.0.CO;2-E","article-title":"Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells","volume":"30","author":"Eberl","year":"2000","journal-title":"Eur. J. Immunol."},{"key":"2025032411502935300_r71","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1084\/jem.192.7.921","article-title":"Natural killer T cell activation inhibits hepatitis B virus replication in vivo","volume":"192","author":"Kakimi","year":"2000","journal-title":"J. Exp. Med."},{"key":"2025032411502935300_r72","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/s10875-005-8064-5","article-title":"V\u03b114i NKT cells are innate lymphocytes that participate in the immune response to diverse microbes","volume":"25","author":"Kinjo","year":"2005","journal-title":"J. Clin. Immunol."},{"key":"2025032411502935300_r73","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/intimm\/12.7.987","article-title":"The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes","volume":"12","author":"Nishimura","year":"2000","journal-title":"Int. Immunol."},{"key":"2025032411502935300_r74","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S1040-8428(01)00198-6","article-title":"Natural killer T (NKT) cells and their role in antitumor immunity","volume":"41","author":"Brutkiewicz","year":"2002","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"2025032411502935300_r75","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1080\/10428190600682688","article-title":"CD1d expression level in tumor cells is an important determinant for anti-tumor immunity by natural killer T cells","volume":"47","author":"Haraguchi","year":"2006","journal-title":"Leuk. Lymphoma"},{"key":"2025032411502935300_r76","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/ijc.11723","article-title":"CD1d is expressed on B-chronic lymphocytic leukemia cells and mediates \u03b1-galactosylceramide presentation to natural killer T lymphocytes","volume":"109","author":"Fais","year":"2004","journal-title":"Int. J. Cancer"},{"key":"2025032411502935300_r77","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/sj.leu.2403671","article-title":"CD1d expression on B-precursor acute lymphoblastic leukemia subsets with poor prognosis","volume":"19","author":"Fais","year":"2005","journal-title":"Leukemia"},{"key":"2025032411502935300_r78","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.4049\/jimmunol.176.8.4581","article-title":"Oral nickel tolerance: Fas ligand-expressing invariant NK T cells promote tolerance induction by eliciting apoptotic death of antigen-carrying, effete B cells","volume":"176","author":"Nowak","year":"2006","journal-title":"J. Immunol."},{"key":"2025032411502935300_r79","doi-asserted-by":"crossref","first-page":"5338","DOI":"10.4049\/jimmunol.158.11.5338","article-title":"Involvement of NK1+CD4\u2212CD8\u2212 \u03b1\u03b2 T cells and endogenous IL-4 in non-MHC-restricted rejection of embryonal carcinoma in genetically resistant mice","volume":"158","author":"Nakamura","year":"1997","journal-title":"J. Immunol."},{"key":"2025032411502935300_r80","doi-asserted-by":"crossref","first-page":"10902","DOI":"10.1073\/pnas.1834479100","article-title":"CD4+CD25+ T cells responding to serologically defined autoantigens suppress antitumor immune responses","volume":"100","author":"Nishikawa","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025032411502935300_r81","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1084\/jem.20042280","article-title":"Sequential activation of NKT cells and NK cells provides effective innate immunotherapy of cancer","volume":"201","author":"Smyth","year":"2005","journal-title":"J. Exp. Med."},{"key":"2025032411502935300_r82","doi-asserted-by":"crossref","first-page":"897","DOI":"10.4049\/jimmunol.161.2.897","article-title":"T cell-mediated, IFN-\u03b3-facilitated rejection of murine B16 melanomas","volume":"161","author":"B\u00f6hm","year":"1998","journal-title":"J. Immunol."},{"key":"2025032411502935300_r83","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00008390-200102000-00003","article-title":"Comparative analysis of immunocritical melanoma markers in the mouse melanoma cell lines B16, K1735 and S91-M3","volume":"11","author":"Peter","year":"2001","journal-title":"Melanoma Res."},{"key":"2025032411502935300_r84","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/ni827","article-title":"Prolonged IFN-\u03b3-producing NKT response induced with \u03b1-galactosylceramide-loaded DCs","volume":"3","author":"Fujii","year":"2002","journal-title":"Nat. Immunol."},{"key":"2025032411502935300_r85","doi-asserted-by":"crossref","first-page":"11252","DOI":"10.1073\/pnas.0604812103","article-title":"Glycolipid \u03b1-C-galactosylceramide is a distinct inducer of dendritic cell function during innate and adaptive immune responses of mice","volume":"103","author":"Fujii","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025032411502935300_r86","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1349-7006.2008.00730.x","article-title":"Clinical applications of natural killer T cell-based immunotherapy for cancer","volume":"99","author":"Motohashi","year":"2008","journal-title":"Cancer Sci."}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/185\/5\/2721\/61611269\/1001018.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/185\/5\/2721\/61611269\/1001018.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T23:44:23Z","timestamp":1743205463000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/185\/5\/2721\/7977735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,1]]},"references-count":86,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,9,1]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.1001018","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2010,9]]},"published":{"date-parts":[[2010,9,1]]}}}